Orchestra BioMed raises $110M, inks Medtronic partnership

Biomedical company Orchestra BioMed partnered with Medtronic and snagged $110 million in a Series D funding round.

Orchestra BioMed founded in 2017 out of New Hope, Penn. is a biomedical company that brings high-impact medical technology to patients through collaboration and risk-reward partnerships, according to a June 29 press release.

 Three takeaways from the collaboration:

  1. Orchestra BioMed and Medtronic will partner to develop a potential treatment for patients with hypertension who have a cardiac pacemaker.
  2. The $110 million in financing is managed by RTW Investments, Perspective Advisors, Terumo, SternAegis Ventures and others.
  3. Orchestra BioMed now has enough capital that it expects to be able to fund operations into 2026.

 

Latest articles on healthcare information technology:

Graphite Health hires Baylor Scott & White Health's chief legal officer
16 recent health IT innovations, partnerships
Tampa General Hospital launches home-based healthcare

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Whitepapers

Featured Webinars